SCHEMBL13077703

SCHEMBL13077703

CCCC(=O)Nc1ccc(OCC(CNC(C)C)OC(=O)COCCON(O)O)c(C(C)=O)c1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 5/20 0.62
▸ ADRB1 P08588 3/20 0.62
▸ SLC22A1 O15245 1/20 0.62
▸ LMNA P02545 1/20 0.62
▸ HIF1A Q16665 1/20 0.62
▸ KDM4E B2RXH2 1/20 0.61
▸ KCNH2 Q12809 1/20 0.41
▸ MCHR1 Q99705 1/20 0.34
▸ ABCB1 P08183 1/20 0.33
▸ ESRRA P11474 1/20 0.32
▸ CDYL Q9Y232 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ ADRB3 P13945 1/20 0.31
▸ PTPRC P08575 2/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ F2R P25116 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13077479 0.90 ADRB2 (0.64) ADRB2ADRB1SLC22A1LMNAHIF1A
SCHEMBL13077699 0.88 ADRB2 (0.49) ADRB2ADRB1SLC22A1LMNAHIF1A
SCHEMBL13040051 0.88 ADRB2 (0.60) ADRB2ADRB1SLC22A1LMNAHIF1A
SCHEMBL13077500 0.84 ADRB2 (0.62) ADRB2ADRB1SLC22A1LMNAHIF1A
SCHEMBL13040049 0.79 LMNA (0.62) ADRB2ADRB1SLC22A1LMNAHIF1A
SCHEMBL13077701 0.79 ADRB2 (0.59) ADRB2ADRB1SLC22A1LMNAHIF1A
SCHEMBL13077501 0.78 LMNA (0.51) ADRB2ADRB1SLC22A1LMNAHIF1A
Acebutolol SCHEMBL5360413 0.77 ADRB2 (1.00) ADRB2ADRB1SLC22A1LMNAHIF1A
Acebutolol SCHEMBL3772 0.77 ADRB2 (1.00) ADRB2ADRB1SLC22A1LMNAHIF1A
Acebutolol SCHEMBL5360409 0.77 ADRB2 (1.00) ADRB2ADRB1SLC22A1LMNAHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825263-B2 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive NICOX S.A. (FR) 2010-11-02 — — US disclosed
Send feedback